Annual Net Margin
N/A
31 December 2023
Summary:
Inhibikase Therapeutics annual net profit margin is not available.IKT Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
30 September 2024
Summary:
Inhibikase Therapeutics quarterly net profit margin is not available.IKT Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
IKT Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Inhibikase Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -1361.26%(+603.9%) |
| June 2021 | - | -193.40%(+3.2%) |
| Mar 2021 | - | -187.40%(-73.6%) |
| Dec 2020 | -407.73% | -708.85%(-60.2%) |
| Sept 2020 | - | -1779.72%(+826.4%) |
| June 2020 | - | -192.12%(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -202.17%(+13.0%) |
| Dec 2019 | -509.73%(+856.9%) | -178.97%(-81.6%) |
| Sept 2019 | - | -974.37%(-30.6%) |
| June 2019 | - | -1404.30%(+378.1%) |
| Mar 2019 | - | -293.75% |
| Dec 2018 | -53.27% | - |
FAQ
- What is the all time high annual net margin for Inhibikase Therapeutics?
- What is the all time high quarterly net margin for Inhibikase Therapeutics?
What is the all time high annual net margin for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual net profit margin is -53.27%
What is the all time high quarterly net margin for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly net profit margin is -178.97%